Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 2/13/2025 | $38.00 | Buy | UBS |
| 12/6/2024 | $63.00 | Outperform | BMO Capital Markets |
| 9/9/2024 | $70.00 | Mkt Outperform | JMP Securities |
| 7/8/2024 | $90.00 | Buy | BTIG Research |
| 6/27/2024 | $86.00 | Buy | Stifel |
| 5/6/2024 | $65.00 | Buy | H.C. Wainwright |
| 4/3/2024 | $65.00 | Outperform | Evercore ISI |
| 3/28/2024 | $70.00 | Outperform | RBC Capital Mkts |
UBS initiated coverage of Jasper Therapeutics with a rating of Buy and set a new price target of $38.00
BMO Capital Markets initiated coverage of Jasper Therapeutics with a rating of Outperform and set a new price target of $63.00
JMP Securities initiated coverage of Jasper Therapeutics with a rating of Mkt Outperform and set a new price target of $70.00
8-K - Jasper Therapeutics, Inc. (0001788028) (Filer)
DEFA14A - Jasper Therapeutics, Inc. (0001788028) (Filer)
DEF 14A - Jasper Therapeutics, Inc. (0001788028) (Filer)
4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)